The crucial role of ZEB2: From development to epithelial‐to‐mesenchymal transition and cancer complexity

• Published in: Journal of cellular physiology Vol. 234; no. 9; pp. 14783 - 14799
• Main Authors: Fardi, Masoumeh, Alivand, Mohammadreza, Baradaran, Behzad, Farshdousti Hagh, Majid, Solali, Saeed
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.09.2019
• Subjects: Apoptosis; Binding; Biological properties; Cancer; cancer stem cell; Cell cycle; Cell survival; Complexity; Drug resistance; EMT; epigenetics; Homeobox; Mesenchyme; Metastases; Stem cells; target therapy; ZEB2; Zinc finger proteins; ZEB2; cancer; cancer stem cell; EMT; epigenetics; target therapy
• ISSN: 0021-9541; 1097-4652; 1097-4652
• DOI: 10.1002/jcp.28277

Zinc finger E‐box binding homeobox 2 (ZEB2) is a DNA‐binding transcription factor, which is mainly involved in epithelial‐to‐mesenchymal transition (EMT). EMT is a conserved process during which mature and adherent epithelial‐like state is converted into a mobile mesenchymal state. Emerging data indicate that ZEB2 plays a pivotal role in EMT‐induced processes such as development, differentiation, and malignant mechanisms, for example, drug resistance, cancer stem cell‐like traits, apoptosis, survival, cell cycle arrest, tumor recurrence, and metastasis. In this regard, the understanding of mentioned subjects in the development of normal and cancerous cells could be helpful in cancer complexity of diagnosis and therapy. In this study, we review recent findings about the biological properties of ZEB2 in healthy and cancerous states to find new approaches for cancer treatment. In this study, we review recent findings about the biological properties of Zinc finger E‐box binding homeobox 2 in healthy and cancerous states to find new approaches for cancer treatment.